| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406641A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 04/14/2004 | EP1406639A2 Method for enhancing the effectiveness of cancer therapies |
| 04/14/2004 | EP1406634A1 Combination of drospirenone and an estrogen sulphamate for hrt |
| 04/14/2004 | EP1406632A2 Substituted 3-aryl-5-aryl- 1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406616A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 04/14/2004 | EP1406615A1 Kinase inhibitors and the use thereof |
| 04/14/2004 | EP1406613A1 Organic nitrate-based compounds for the treatment of vasculopathies |
| 04/14/2004 | EP1406611A2 Method for treating fibrotic diseases or other indications |
| 04/14/2004 | EP1406610A1 Use of substituted gamma-lactone compounds as medicaments |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406600A1 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 04/14/2004 | EP1380295A9 Photosensitiser and method for production thereof |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands |
| 04/14/2004 | EP1189583A4 Indole derivatives |
| 04/14/2004 | EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 04/14/2004 | EP1171440B1 Substituted-3-cyano-[1.7],[1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 04/14/2004 | EP1155012B1 Anti-cancer dihydroquinazoline derivatives |
| 04/14/2004 | EP1131297B1 Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 04/14/2004 | EP1121426B1 Method for triggering apoptosis in cells |
| 04/14/2004 | EP1073641B1 New substituted amides, their production and their use |
| 04/14/2004 | EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 04/14/2004 | EP0979240B1 Serine protease inhibitors |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 04/14/2004 | CN1489583A Novel physiologically active substance |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489477A Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489469A Medicine for lung cnncer |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1489466A Parenteral dosage containing epothilones |
| 04/14/2004 | CN1489447A Method and device for measuring body composition |
| 04/14/2004 | CN1488624A Novel substituted propanamide benzoyl urea derivatives, medicinal composition containg same and use thereof |
| 04/14/2004 | CN1488395A Java brucea oil-emulsion injecta with low-toxicity and preparing method thereof |
| 04/14/2004 | CN1488392A Chinese medicine composition for accessory treatment of primary liver cancer and preparing method thereof |
| 04/14/2004 | CN1488347A Use of raloxifene for preparing medicine for treating, fibroid and endometriosis |
| 04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
| 04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
| 04/14/2004 | CN1145623C Imidazole derivatives |
| 04/14/2004 | CN1145618C Cycloformate derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/14/2004 | CN1145610C Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145496C Novel formulation for peptide release |
| 04/13/2004 | US6720445 Acetyloxymethyl esters and methods for using the same |
| 04/13/2004 | US6720427 Used to treat abnormal cell growth and central nervous system disorders |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720343 (((4-(3-thien-2-yl-1,2,4-oxadiazol-5-yl)phenyl)sulfonyl) amino)acetic acid, optionally substituted; selective matrix metalloprotease (mmp-2) inhibition; low protein binding, high blood concentration, no p-450 inhibition |
| 04/13/2004 | US6720337 Antitumor agents; synergistic mixtures; side effect reduction |
| 04/13/2004 | US6720332 Oxindole derivatives |
| 04/13/2004 | US6720331 Having anti-mitotic activity for therapy of cancer |
| 04/13/2004 | US6720329 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) |
| 04/13/2004 | US6720327 Lactone integrin antagonists |
| 04/13/2004 | US6720323 Colchinol derivatives as angiogenesis inhibitors |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6720311 To cause apoptosis in colon cancer and prostate cancer cells |
| 04/13/2004 | US6720304 Conjugate comprising a folic acid antagonist and a carrier |
| 04/13/2004 | US6720181 Ubiquitin ligases as therapeutic targets |
| 04/13/2004 | US6720146 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of ovarian cancer |
| 04/13/2004 | US6719971 Method for making humanized antibodies |
| 04/13/2004 | CA2182397C Endotoxin reduction or removal process |
| 04/08/2004 | WO2004029291A1 Method of evaluationg canceration degree of mammal-origin specimen |
| 04/08/2004 | WO2004029287A2 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/08/2004 | WO2004029244A1 Animal cells having chimeric receptor and utilization thereof |
| 04/08/2004 | WO2004029104A1 Phospholipid derivative |
| 04/08/2004 | WO2004029092A2 Antibody for adcc and inducing cytokine production |
| 04/08/2004 | WO2004029089A2 Novel angiogenesis target and uses thereof |
| 04/08/2004 | WO2004029054A1 Novel adenine compound and use thereof |
| 04/08/2004 | WO2004029046A2 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 04/08/2004 | WO2004029038A1 Novel pyrimidineamide derivatives and the use thereof |
| 04/08/2004 | WO2004028564A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 04/08/2004 | WO2004028558A1 Preventives/remedies for neurodegenerative disease |
| 04/08/2004 | WO2004028557A1 Stabilized protein compositions |
| 04/08/2004 | WO2004028553A1 A method of modulating cellular development |
| 04/08/2004 | WO2004028552A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | WO2004028549A1 A coixenolide capsules for treating prostate disease |
| 04/08/2004 | WO2004028541A2 Composition for the treatment of nasopharyngeal carcinoma and use thereof |
| 04/08/2004 | WO2004028534A1 Controlled releases system containing temozolomide |
| 04/08/2004 | WO2004028527A1 Synergistic combinations of dietary fiber and n-saids for the treatment of cancer |
| 04/08/2004 | WO2004018481A3 Gossypol derivatives, production methods thereof and uses of same |
| 04/08/2004 | WO2004017992A3 Ptk7 protein involvement in carcinoma |
| 04/08/2004 | WO2004016613A3 Purine derivatives and their use as antiproliferative agents |
| 04/08/2004 | WO2004014150A9 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 04/08/2004 | WO2004009072A3 Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2004006937A3 Novel pharmaceutical compositions based on 5-alpha-reductase inhibitors and uses of same |
| 04/08/2004 | WO2004005350A3 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/08/2004 | WO2004001004A3 Membrane associated tumor endothelium markers |
| 04/08/2004 | WO2003106431A3 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 04/08/2004 | WO2003105769A3 Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |